In Vitro Activities of Designed Antimicrobial Peptides Against Multidrug-Resistant Cystic Fibrosis Pathogens

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.43.6.1435
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

In Vitro Antimicrobial and Antioxidant Activities of Monoterpenes Against Some Food-Borne Pathogens

Journal of Plant Protection and Pathology
2019English

In Vitro Activities of Antibiotics and Antimicrobial Cationic Peptides Alone and in Combination Against Methicillin-Resistant Staphylococcus Aureus Biofilms

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2012English

A Trans-Kingdom Antimicrobial Peptide Targeting Cystic Fibrosis Pathogens

Journal of Genetic Syndromes & Gene Therapy
2016English

Multidrug-Resistant Nontuberculous Mycobacteria Isolated From Cystic Fibrosis Patients

Journal of Clinical Microbiology
Microbiology
2014English

Comparative in Vitro Activities of Daptomycin and Vancomycin Against Resistant Gram-Positive Pathogens

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2000English

Covalent Dimer Species of -Defensin Defr1 Display Potent Antimicrobial Activity Against Multidrug-Resistant Bacterial Pathogens

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2007English

Engineered Cationic Antimicrobial Peptides to Overcome Multidrug Resistance by ESKAPE Pathogens

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2014English

In Vitro Activities of the Novel Cephalosporin LB 11058 Against Multidrug-Resistant Staphylococci and Streptococci

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2004English

Antibacterial Activity of Marine Microalgae Against Multidrug Resistant Human Pathogens

International Journal on Applied Bio-Engineering
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy